Skip to main content
OpenTrials
Completed

NCT Number: NCT06906913

Oral and Anal Swab Sampling in Patients With HPV Positivity

Patients whose pathology results are reported as cervical intraepithelial neoplasia (CIN) 1, CIN 2, and CIN 3, are recruited. We aimed to evaluate HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, by collecting oropharyngeal and anal swab samples. A total of 30 women of reproductive age, who consented to participate, were included in the study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HPV

Age range

18 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Gaziantep Cengiz Gokcek Women's, Obstetrics and Pediatrics Hospital

Gaziantep, 27010, Turkey (Türkiye)

About this study

Human papillomavirus (HPV) positivity is associated with cervical, oropharyngeal, and anal cancers. There is insufficient data in the current literature regarding the effectiveness of obtaining oropharyngeal and anal swabs from patients with HPV positivity is an effective method for detecting potential pathologies. HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, will be evaluated by collecting oropharyngeal and anal swab samples.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3

Exclusion criteria

  • HPV-negative women

Treatment and study plan

HPV testing

Diagnostic Test

Oropharyngeal and anal swab samples are evaluated in the Microbiology laboratory for the existence of HPV.

Primary outcomes

  1. Oropharyngeal Swab Sample - HPV Testing

    Time frame: 1 month

    Presence of HPV will be tested

  2. Anal Swab Sample - HPV Testing

    Time frame: 1 month

    Presence of HPV

Secondary outcomes

  1. Oropharyngeal Swab Sample - HPV Testing (if positive)

    Time frame: 1 month

    Type of HPV

  2. Anal Swab Sample - HPV Testing (if positive)

    Time frame: 1 month

    Type of HPV

Sponsors and collaborators

Lead sponsor

Medipol University

Other

Collaborators

  • gaziantep university medicine faculty

Registry information

Official study title

Evaluation of Oropharyngeal and Anal Swab Samples in Patients With HPV Positivity

Acronym: Oral Anal HPV

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Apr 2, 2025
Registry last updated
Apr 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.